Education
About Us
Working with TipRanks
Follow Us
Galecto (GLTO)
NASDAQ:GLTO
GLTO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.01 - $16.05
Previous CloseN/A
Volume2.41K
Average Volume (3M)63.54K
Market Cap
$4.44M
Enterprise Value-$7.53M
Total Cash (Recent Filing)$11.94M
Total Debt (Recent Filing)$60.00K
Price to Earnings (P/E)―
Beta2.13
Next Earnings
Jul 30, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.92
Shares Outstanding1,322,359
10 Day Avg. Volume24,792
30 Day Avg. Volume63,542
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)0.32
Price to Sales (P/S)0.00
P/FCF Ratio-0.29
Enterprise Value/Market Cap-1.69
Enterprise Value/Revenue-3.13
Enterprise Value/Gross Profit54.95
Enterprise Value/Ebitda0.09
Forecast
1Y Price Target
$10.00Price Target Upside197.62% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
Galecto News
PremiumCompany Announcements
Galecto, Inc. Focuses on Oncology and Liver Diseases
Options Prices
Currently, No data available
---
Ownership Overview
2.56% Insiders
1.41% Mutual Funds
7.56% Other Institutional Investors
87.83% Public Companies and Individual Investors
GLTO FAQ
What was Galecto’s price range in the past 12 months?
Galecto lowest stock price was $2.01 and its highest was $16.05 in the past 12 months.
What is Galecto’s market cap?
Galecto’s market cap is $4.44M.
When is Galecto’s upcoming earnings report date?
Galecto’s upcoming earnings report date is Jul 30, 2025 which is in 48 days.
How were Galecto’s earnings last quarter?
Galecto released its earnings results on May 08, 2025. The company reported -$1.92 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.92.
Is Galecto overvalued?
According to Wall Street analysts Galecto’s price is currently Undervalued.
Does Galecto pay dividends?
Galecto does not currently pay dividends.
What is Galecto’s EPS estimate?
Galecto’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Galecto have?
Galecto has 1,322,359 shares outstanding.
What happened to Galecto’s price movement after its last earnings report?
Galecto reported an EPS of -$1.92 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.521%.
Which hedge fund is a major shareholder of Galecto?
Currently, no hedge funds are holding shares in GLTO
Company Description
Galecto
Galecto, Inc. (GLTO) is a biotechnology company focused on the development of novel therapeutics for the treatment of fibrotic diseases, cancer, and other related conditions. The company is primarily engaged in the research and development of small molecule inhibitors that target galectin proteins, which are involved in various biological processes. Galecto's lead product candidates are designed to address unmet medical needs in fibrotic and inflammatory diseases, offering innovative solutions aimed at improving patient outcomes.